INCY vs VTRS — Key Metrics

Metric INCY (INCYTE CORP) VTRS (VIATRIS INC)
Price117.820.28
Market Cap24.01 Billion23.25 Billion
P/E (TTM)56.36-38.26
P/B (Quarterly)4.2191.589
P/S (TTM)3.991.58
Net Profit Margin (TTM)6.7-4.1
Gross Margin (TTM)92.735.3
ROE (TTM)7.1-4.2
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

INCYTE CORP
vs
 
VIATRIS INC
 
INCYTE CORP
vs
 
VIATRIS INC
Performance Comparison
AI Model Recommendation
INCY · INCYTE CORP

Greatly Outperform

84
UnderperformOutperform
VTRS · VIATRIS INC

Greatly Outperform

67
UnderperformOutperform
Recommendation Summary

Both stocks are projected to significantly outperform the market over the next year. If you have to make a choice, Upfront Recommendation: INCY.

Financial Metrics
Prices delayed ~15 min
INCY Metrics VTRS
$117.80 Price $20.28
— Market Capitalization —
3.99 Price to Sales 1.58
35.06 Price to FCF Ratio 10.85
4.31 Price to Gross Profit 4.47
6.99 Price to R&D 23.17
4.35 Price to Current Assets 2.26

INCY vs VTRS at a glance

Incyte Corp (INCY) and Viatris INC (VTRS) are both in the Healthcare sector. They are similar in size: $24.0 billion and $23.3 billion in market value.

On trailing-twelve-month figures, INCY trades at 4.0 times trailing sales and VTRS at 1.6; net profit margins are 6.7% and -4.1%.

The Upfront Investment model currently rates both Greatly Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.